This profile was last updated on . .
Is this you? Claim your profile.
Vice President Clinical Development
Inovio Biomedical Corporation
10480 Wateridge Circle
San Diego, California 92121
Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that is generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates... more
Senior Vice President and Chief Medical Officer
Senior Vice President and Chief Marketing Officer
Vice President of Global Medical Affairs of Oncology
Vice President, Global Head Medical Affairs and PV, Medical Diagnostics and NPD
Senior Director, Oncology
University of Virginia's School of Medicine
Mark Stephen Gelder
, M.D., an experienced gynecologic oncologist, was appointed Vice President, Clinical Development to lead Inovio's clinical development of its immunotherapies against HPV-caused cervical cancer and dysplasia, including our planned phase III study for VGX-3100.
Heron Therapeutics . A Specialty Pharmaceutical Company â€¢ Investor Relations â€¢ News Release
Heron Therapeutics . A Biotechnology Company â€¢ Investor Relations â€¢ 2012 News Releases
Heron Therapeutics . A Biotechnology Company â€¢ Investor Relations â€¢ News Release
Clinical Research News and Views on the Global Clinical Trials Industry | CenterWatch News Online
Jay Van Gelder
Stephan van Gelder
Erik van Gelder
Gideon van Gelder
Gideon Van Gelder